Search Results for "Http Dx Doi Org 10 1002 Adma 201104290"
Matching Channels
PKC (protein kinase C) http://www.bioportfolio.com/channels/serine-threonine-protein-kinase-c-pkc is a kinase enzyme and a protein molecule that can change the format of other proteins through chemi...
Myc is the protein encoded by the MYC gene that activates the cell cycle
Myc is the protein encoded by the MYC gene that activates the cell cycle. It promotes cell replication through genetic coding for p14, inhibiting MDM2 and preventing the degradation of the pro-apopt...
APC stands for adenomatous polyposis coli, a form of colorectal cancer and is a tumour suppressor
APC stands for adenomatous polyposis coli, a form of colorectal cancer and is a tumour suppressor. When APC it mutated, it can cause this particular type of colorectal cancer. When not present in it...
Despite the humorous name, hedgehog signalling cascades are central to embryonic development and has been implicated in the development of a number of diseases, including cancer. The downstream ca...
Wnt is an anti-apoptotic ligand for the Fz (frizzled) receptor on cell membranes
Wnt is an anti-apoptotic ligand for the Fz (frizzled) receptor on cell membranes, meaning it attaches to the Fz receptor and prevents cell death (in effect with other cellular stimuli). Wnt molecule...
Matching News
ADMA Biologics appoints Lawrence Guiheen to board of directors
Late-stage biotech firm ADMA Biologics has announced it has appointed Lawrence Guiheen to its board of directors. Guiheen said: “Having previously served as president of BioPharmaceuticals for Baxte...
Biotest and ADMA Biologics agree to deal for immune globulin
Biotest Pharmaceuticals has entered a 10-year deal to act as the exclusive global supplier to ADMA Biologics for respiratory -More-
Biotest, ADMA sign manufacturing deal
Biotest Pharmaceuticals (BPC), a wholly owned US subsidiary of Biotest, and ADMA Biologics have signed a strategic long-term manufacturing, supply and licensing deal.
[ADMA Biologics] files for its IPO, later sets price range
A year after going public through a reverse merger with R&R Acquisition, plasma therapeutics company [ADMA Biologics Inc.] has followed through on its plans to list on the OTCBB, and has filed for its...
ADMA Biologics to Present at the Rodman & Renshaw Annual Global Investment Conference
ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today announced i...
ADMA Biologics initiates enrollment in RI-002 Phase III study for PIDD
ADMA Biologics, Inc. (ADMA), a specialty immune globulin company that develops, manufactures and intends to market plasma-based biologics for the treatment and prevention of certain infectious disease...
[ADMA] and [Biotest] enter cross-licensing and manufacturing agreements
Plasma therapeutics companies [ADMA Biologics Inc.] and [Biotest AG] have entered into multiple agreements surrounding the manufacturing and marketing of two immune globulin programs. Initially, the...
ADMA Biologics Inc. (Hackensack, N.J.) amended its IPO and said it plans to sell 2.1 million shares at $13.50-$15.50. A $14.50 price would raise $30.5 million and value the company at $97.5 million. O...
Matching PubMed Articles
Asymmetric dimethylarginine (ADMA) causes endothelial dysfunction by inhibiting endothelial nitric oxide synthase. Elevated ADMA plasma levels comprise a major risk factor for coronary artery disease...
ADMA and NOS regulation in chronic renal disease: beyond the old rivalry for l-arginine.
Chronic kidney disease is associated with increased levels of assymetric N(G),N(G)-dimethylarginine (ADMA), which is predictive of increased mortality and cardiovascular disease. ADMA induces endothel...
INTRODUCTION: Free asymmetric dimethylarginine (ADMA) is a competitive inhibitor of the nitric oxide synthases (NOS). Suppression of nitric oxide (NO) synthesis increases the ris...
An increasing number of reports in the literature indicate that asymmetric dimethylarginine (ADMA) regulates nitric oxide generation in numerous disease states. ADMA has been less studied in psychiatr...
BACKGROUND: Recent studies have suggested that impaired nitric oxide (NO) formation in preeclampsia may result from increased concentrations of an endogenous NO synthase inhibitor, the asymmetric dime...
